Seminars in Immunology

Papers
(The TQCC of Seminars in Immunology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Editorial Board177
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity156
Differential immune responses behind different celiac disease manifestations90
Cellular stress and macrophage activation80
Exploiting antifungal immunity in the clinical context66
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells62
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer60
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi59
Pyroptosis modulation by bacterial effector proteins55
Local and Cell-intrinsic complement: The new player in cancer progression52
Aging of lymphoid stromal architecture impacts immune responses50
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity49
Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges44
Resolving inflammatory links between myocardial infarction and vascular dementia44
Editorial Board44
Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)42
Microbial metabolites and immunotherapy: Basic rationale and clinical indications42
Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity41
Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?40
Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease39
Immunity to pathogenic fungi in the eye39
Pyroptosis: A road to next-generation cancer immunotherapy37
Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity36
Pyroptosis and the cellular consequences of gasdermin pores35
Interplay between the complement system and other immune pathways in the tumor microenvironment34
The noncanonical inflammasome-induced pyroptosis and septic shock34
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment33
Western diet influences on microbiome and carcinogenesis33
Introduction to the special issue: Neutrophils in the tumor microenvironment31
Immunity to fungi: Editorial overview30
Cellular and molecular diversity in spondyloarthritis30
The paradox of aging: Aging-related shifts in T cell function and metabolism29
Specialized pro-resolving mediators as modulators of immune responses29
Adaptive NK cell response to human cytomegalovirus: Facts and open issues28
The evolving biology of cross-presentation28
Cellular and molecular diversity in Sjogren’s syndrome salivary glands: Towards a better definition of disease subsets27
Neuroimmune interactions between itch neurons and skin microbes25
Autoimmune diabetes and targets for immunomodulation25
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases24
TREM2: A new player in the tumor microenvironment24
Recent developments in C3-targeted complement therapeutics23
Antigen discovery for the development of cancer immunotherapy23
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy22
The dual role of neutrophils in cancer22
Thymus aging and immune reconstitution, progresses and challenges22
Sialic acid and Siglec receptors in tumor immunity and immunotherapy22
Introduction to the Special Issue: Nutrition, microbiota and immunity21
Complement C3-targeted therapy in C3 glomerulopathy, a prototype of complement-mediated kidney diseases21
T cell control of SARS-CoV-2: When, which, and where?21
Age-dependent changes in T follicular helper cells shape the humoral immune response to vaccination20
Individual- and population-associated heterogeneity in vaccine-induced immune responses. The impact of inflammatory status and diabetic comorbidity20
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinic20
The tissue glycome as regulator of immune activation and tolerance mediated by C-type lectins and Siglecs20
T cell fate decisions during memory cell generation with aging20
Targeting the tissue-complosome for curbing inflammatory disease19
The immunological processes behind aquaporin 4-antibody seropositive neuromyelitis optica spectrum disorders19
Publisher's note: Welcome Prof. Guido Kroemer19
What fungal CNS infections can teach us about neuroimmunology and CNS-specific immunity19
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy19
Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?19
Editorial Board18
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells18
Better safe than sorry: Naive T-cell dynamics in healthy ageing18
0.16644597053528